mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |